OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
051500$24200.0058

CJ Freshway Corp

Food Retail & DistributionVerified

CJ Freshway Corp maintains a capital structure with a debt-to-equity ratio of 1.01, indicating a balanced mix of debt and equity financing. The company's liquidity position is characterized by a current ratio of 0.76, suggesting potential short-term liquidity constraints. Free cash flow stands at 59.66 billion KRW, which supports operational flexibility but is modest relative to total assets. Profitability metrics show a return on equity (ROE) of 11.01% and a return on assets (ROA) of 3.15%, both of which are above the industry median for Food Retail & Distribution. The company's operating margin is 2.57% (calculated from operating income of 89.18 billion KRW on revenue of 3.48 trillion KRW), which is in line with the industry's preferred operating margin range of 2.0% to 3.5%. Geographically, CJ Freshway Corp's revenue is concentrated in South Korea, with no disclosed international segments. The company's business model is heavily dependent on domestic demand, which exposes it to local economic fluctuations and regulatory changes. The company's revenue growth is projected to increase by 4.2% in the current fiscal year and 3.8% in the next fiscal year, based on analyst estimates and historical performance. This growth trajectory is supported by a strong operating cash flow of 127.08 billion KRW and a gross margin of 18.2% (634.17 billion KRW on 3.48 trillion KRW revenue). Risk factors include a medium liquidity risk due to a current ratio below 1.0 and a negative net cash position after subtracting total debt. The company's dilution risk is low, with no significant dilution potential in the near term. Adjustments in the valuation model reflect a conservative approach to debt servicing and capital structure. Recent events include a strong analyst outlook, with a mean price target of 44,000 KRW and a mean recommendation of 1.50 (strong buy to buy). No recent filings or transcripts have been disclosed that would significantly alter the company's strategic direction or financial outlook.

30-day price · 051500(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyCJ Freshway Corp
Ticker051500.KQ
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. CJ Freshway Corp operates in the Food & Drug Retailing sector, primarily generating revenue through the retail and distribution of food products.

Classification. CJ Freshway Corp is classified under the Food Retail & Distribution industry within the Consumer Non-Cyclicals economic sector, with a confidence level of 0.92.

CJ Freshway Corp maintains a capital structure with a debt-to-equity ratio of 1.01, indicating a balanced mix of debt and equity financing. The company's liquidity position is characterized by a current ratio of 0.76, suggesting potential short-term liquidity constraints. Free cash flow stands at 59.66 billion KRW, which supports operational flexibility but is modest relative to total assets. Profitability metrics show a return on equity (ROE) of 11.01% and a return on assets (ROA) of 3.15%, both of which are above the industry median for Food Retail & Distribution. The company's operating margin is 2.57% (calculated from operating income of 89.18 billion KRW on revenue of 3.48 trillion KRW), which is in line with the industry's preferred operating margin range of 2.0% to 3.5%. Geographically, CJ Freshway Corp's revenue is concentrated in South Korea, with no disclosed international segments. The company's business model is heavily dependent on domestic demand, which exposes it to local economic fluctuations and regulatory changes. The company's revenue growth is projected to increase by 4.2% in the current fiscal year and 3.8% in the next fiscal year, based on analyst estimates and historical performance. This growth trajectory is supported by a strong operating cash flow of 127.08 billion KRW and a gross margin of 18.2% (634.17 billion KRW on 3.48 trillion KRW revenue). Risk factors include a medium liquidity risk due to a current ratio below 1.0 and a negative net cash position after subtracting total debt. The company's dilution risk is low, with no significant dilution potential in the near term. Adjustments in the valuation model reflect a conservative approach to debt servicing and capital structure. Recent events include a strong analyst outlook, with a mean price target of 44,000 KRW and a mean recommendation of 1.50 (strong buy to buy). No recent filings or transcripts have been disclosed that would significantly alter the company's strategic direction or financial outlook.
Key takeaways
  • CJ Freshway Corp has a balanced capital structure with a debt-to-equity ratio of 1.01.
  • The company's ROE of 11.01% and ROA of 3.15% are above industry medians.
  • Revenue is concentrated in South Korea, exposing the company to local economic and regulatory risks.
  • Analysts project moderate revenue growth of 4.2% in the current fiscal year.
  • The company faces medium liquidity risk and a negative net cash position.
  • Analysts have a positive outlook, with a mean price target of 44,000 KRW.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$3.48T
Gross profit$634.17B
Operating income$89.18B
Net income$50.11B
R&D
SG&A
D&A
SBC
Operating cash flow$127.08B
CapEx-$57.41B
Free cash flow$59.66B
Total assets$1.59T
Total liabilities$1.13T
Total equity$455.18B
Cash & equivalents$130.87B
Long-term debt$460.05B
Valuation
Market price$24200.00
Market cap$287.29B
Enterprise value$616.48B
P/E5.7
Reported non-GAAP P/E
EV/Revenue0.2
EV/Op income6.9
EV/OCF4.8
P/B0.6
P/Tangible book0.6
Tangible book$455.18B
Net cash-$329.19B
Current ratio0.8
Debt/Equity1.0
ROA3.1%
ROE11.0%
Cash conversion2.5%
CapEx/Revenue-1.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
Metric051500Activity
Op margin2.6%2.8% medp25 0.9% · p75 5.9%below median
Net margin1.4%1.8% medp25 0.3% · p75 3.6%below median
Gross margin18.2%24.1% medp25 13.8% · p75 31.4%below median
CapEx / revenue-1.7%-2.0% medp25 -3.8% · p75 -1.0%above median
Debt / equity101.0%56.0% medp25 14.0% · p75 113.8%above median
Observations
IR observations
Mean price target44,000.00 KRW
Median price target44,000.00 KRW
High price target48,000.00 KRW
Low price target40,000.00 KRW
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count3.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate5,595.61 KRW
Last actual EPS4,220.70 KRW
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 06:35 UTCJob: 92b51a7a